BTX161 [2052301-24-1]

TargetMol Chemicals

BTX161 [2052301-24-1]

72

2052301-24-1

Research Use Only

BTX161

C15H16N2O3

272.3

BTX161 is a Thalidomide analogue. BTX161 is a potent CKIalpha degrader. In human AML cells, BTX161 mediates the CKIalpha degradation better than Lenalidomide as well as activates DNA damage response (DDR) and p53, and also stabilizes the p53 antagonist MDM2[1].

3 years

Cc1cccc2C(=O)N(Cc12)[C@H]1CCCC(=O)NC1=O

-20°C

12352200